Search results
Added:
1 year ago
Source:
Radcliffe CKM
A recent study published in Circulation: Heart Failure1 has found that multimorbidity, the presence of two or more chronic health conditions, substantially increases the risk of mortality in patients with heart failure who have mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF).The study analyzed data from two major heart failure trials: TOPCAT-Americas (Treatment of Preserved Cardiac…
View more
Renu Virmani
Research Area(s) / Expertise:
Author
Expertise
Milton Packer
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Rebecca Su Li Chew
,
Bui Khiong Chung
,
Hwei Sung Ling
,
et al
Added:
4 months ago
Added:
6 months ago
Source:
Radcliffe Cardiology
A new study published in JACC has evaluated the prevalence and prognostic significance of secondary tricuspid regurgitation (STR) across the spectrum of heart failure with preserved ejection fraction (HFpEF), finding that its presence is strongly associated with pulmonary vascular disease (PVD) and that different mechanisms of STR carry distinct prognoses.¹˒²This observational study analysed data…
View more
Added:
4 months ago
Source:
Radcliffe Cardiology
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease associated with a significant burden of recurrent cardiovascular (CV) events. A new post hoc analysis of the ATTRibute-CM trial suggests that acoramidis, an oral transthyretin (TTR) stabiliser, significantly reduces the cumulative burden of these outcomes.¹MethodologyThis exploratory analysis used data from the phase 3,…
View more
José Ramón González Juanatey
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Mohammed El-Sheikh
,
Nora Olsen El Caidi
,
Aginsha Kandiah
,
et al
Added:
8 months ago
Jack Wei Chieh Tan
Research Area(s) / Expertise:
Job title: Head and Senior Consultant
Author
Dan G Halpern
Job title: MD
Author